je.st
news
Deal makes CSL flu number two
2014-10-27 02:44:35| Biotech - Topix.net
CSL will become the second largest influenza vaccine maker in the world after it said it would pay $US275 million to buy the Novartis' influenza business. The combined business is expected to hit sales of about $US1 billion annually over the next three to five years, CSL said.
Tags: number
makes
deal
flu
Category:Biotechnology and Pharmaceuticals